Chasing Miracles
The author wanted to know why the stem-cell treatments that worked so well for her hobbled dog aren’t being used to put the spring back in humans’ steps. Researchers at Penn’s Institute for Regenerative Medicine explained—and shared some of their own, measured, progress toward successful therapies.
Promise and Politics
While the bioethical debate over stem-cell research rages on, Penn scientists are making progress using adult-human and animal stem cells—and hoping for broader future support for studies using embryonic stem cells.
Penn Pays to Settle Civil Suit in Gelsinger Case
Penn and government settle 1999 gene-therapy case
In Dogged Pursuit of Ocular Health
Therapy that restores dog’s sight could help children
Penn Researcher CouldvLose Drug-Testing Privileges
FDA seeks to ban IHGT’s Wilson from conducting drug trials.
Gelsinger Family and University Settle
Lawsuit settled in Gelsinger case.
Patient’s Family Sues Over Gene Study
Lawsuit filed in Gelsinger death … Settlement follows
Gene Therapy at Penn Should Go Forward
From College Hall: Answering questions on gene-therapy death.
IHGT’s Wilson Outlines Oversight Plans
IHGT announces new procedures
Clinical Trials Put on Hold at Gene-Therapy Lab
FDA suspends gene-therapy research
Gene-Therapy Researchers Probe Patient’s Death
First findings in gene-therapy death
Researchers Seek Answers After Gene-Therapy Patient Dies
Patient in gene-therapy trial dies